• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Mayo Clinic Launches CQI Program to Minimize Complications from Retained Blood in Heart Surgery Patients

by HITC Staff 05/11/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Mayo Clinic Launches CQI Program to Minimize Complications from Retained Blood in Heart Surgery Patients

ClearFlow, a California-based company that develops technology to maximize post-operative blood evacuation after cardiac surgery and Mayo Clinic are launching research a Continuous Quality Improvement (CQI) program for patients recovering from heart surgery. Simon Maltais, MD, PhD, Mayo Clinic Associate Professor of Surgery, Division of Cardiovascular Surgery will serve as the Principal Investigator for the CQI program. 

Recent studies have demonstrated that up to 20% of patients recovering from heart surgery have some form of intervention due to retained blood that can slow recovery and increase the costs of care,” said Edward Boyle, MD, co-founder and Chairman of ClearFlow. “The goal of this study is to implement structured protocols in the ICU that can facilitate improved recovery for patients after heart surgery. These protocols will include use of PleuraFlow® Active Clearance Technology® (ACT®) System, a simple bedside device used to keep chest tubes free from clogging during the first 24–48 hours of recovery after heart surgery.”

An award-winning innovation developed by cardiothoracic surgeons, PleuraFlow ACT has been shown to reduce both Retained Blood Syndrome (RBS) and post-operative atrial fibrillation in published studies. A key aim of this study is to develop structured ICU protocols to minimize the potential for retained blood within the framework of a continuous quality improvement program and measure patient outcomes improvement.

A recent study by independent investigators in Germany, published in the Journal of Thoracic and Cardiovascular Surgery, affirmed a reduction in retained blood interventions required after surgery from 20% to 11% (43% reduction) in all cardiac surgery patients when the PleuraFlow System was used, as well as a reduction in Postoperative Atrial Fibrillation (POAF) from 30% to 20% (a 33% reduction) in propensity matched patients. The study results demonstrate that by implementing a quality improvement protocol to reduce chest tube clogging, complications can be reduced and patient outcomes can be improved. The cost to treat these complications add an enormous burden to the healthcare system.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: ClearFlow, Mayo Clinic

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |